文献速递产科母胎医学生殖医学

人类滋养层细胞侵袭的体外研究

Investigation of human trophoblast invasion in vitro.
PubMed 文献 · Hum Reprod Update · 2020-01-01

该综述讨论研究人类滋养层细胞侵袭的体内外模型,指出当前滋养层细胞系多缺乏EVT标志物HLA-G,且传统侵袭实验难以反映迁移动力学;微流控技术仅需少量原代细胞即可实时监测三维基质中的细胞运动,为研究EVT侵袭动力学提供新工具。

要点

  • 现有滋养层细胞系多不表达EVT标志物HLA-G,应快速更新。
  • 微流控侵袭实验仅需少量细胞,可实时监测三维迁移动力学。
  • 深度侵袭调控异常与子痫前期、FGR、死产和复发性流产相关。

核心结论

  • 深度滋养层侵袭是人类妊娠特有特征,需精细调控以在母胎间分配资源。
  • 现有滋养层细胞系多缺乏EVT标志物HLA-G,应被干细胞/类器官来源的新EVT细胞系取代。
  • 微流控实验可实时监测细胞运动,是研究滋养层侵袭动力学的有力工具。

研究设计与样本

  • 综述,通过PubMed检索相关研究,最后更新于2020年2月。
  • 检索统计近5年使用JEG-3、BeWo、JAR、HTR-8/Svneo、Swan-71细胞系及原代人EVT的期刊文章数量。

主要发现

  • 现有滋养层细胞系多不表达EVT定义性标志物HLA-G。
  • 传统终点侵袭实验缺乏生理相关性且迁移动力学简化。
  • 微流控实验仅需少量细胞嵌入三维细胞外基质,可实时监测迁移。
  • 干细胞和类器官技术已用于胚胎外组织,建立可在2D和3D生长并分化为EVT的滋养层细胞系。

关键数值与推荐

  • EVT定义性标志物为HLA-G,但多数现有滋养层细胞系缺乏其表达。

临床怎么用

  • 研究滋养层侵袭应优先选用可表达HLA-G并分化为EVT的新细胞系。
  • 需动态分析侵袭时,可选用微流控实验实时监测细胞运动。

局限性

  • 缺乏非恶性且具EVT表型的细胞系。
  • 原代EVT数量少,限制传统侵袭实验的应用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In humans, inadequate trophoblast invasion into the decidua is associated with the 'great obstetrical syndromes' which include pre-eclampsia, foetal growth restriction (FGR) and stillbirth. The mechanisms regulating invasion remain poorly understood, although interactions with the uterine environment are clearly of central importance. Extravillous trophoblast (EVT) cells invade the uterus and transform the spiral arteries. Progress in understanding how they invade has been limited due to the lack of good in vitro models. Firstly, there are no non-malignant cell lines that have an EVT phenotype. Secondly, the invasion assays used are of limited use for the small numbers of primary EVT available from first-trimester placentas. We discuss recent progress in this field with the generation of new EVT lines and invasion assays using microfluidic technology. OBJECTIVE AND RATIONALE: Our aim is to describe the established models used to study human trophoblast invasion in vivo and in vitro. The difficulties of obtaining primary cells and cell lines that recapitulate the phenotype of EVT are discussed together with the advantages and pitfalls of the different invasion assays. We compare these traditional end point assays to microfluidic assays where the dynamics of migration can be measured. SEARCH METHODS: Relevant studies were identified by PubMed search, last updated on February 2020. A search was conducted to determine the number of journal articles published using the cell lines JEG-3, BeWo, JAR, HTR-8/Svneo, Swan-71 and primary human extravillous trophoblast in the last 5 years. OUTCOMES: Deep trophoblast invasion into the maternal decidua is a particular feature of human pregnancy. This invasion needs to be finely regulated to allocate resources between mother and baby. A reliable source of EVT is needed to study in vitro how the uterine environment regulates this process. First, we critically discuss the issues with the trophoblast cell lines currently used; for example, most of them lack expression of the defining marker of EVT, HLA-G. Recently, advances in human stem cell and organoid technology have been applied to extraembryonic tissues to develop trophoblast cell lines that can grow in two (2D) and three dimensions (3D) and differentiate to EVT. This means that the 'trophoblast' cell lines currently in use should rapidly become obsolete. Second, we critically discuss the problems with assays to study trophoblast invasion. These lack physiological relevance and have simplified migration dynamics. Microfluidic assays are a powerful tool to study cell invasion because they require only a few cells, which are embedded in 3D in an extracellular matrix. Their major advantage is real-time monitoring of cell movement, enabling detailed analysis of the dynamics of trophoblast migration. WIDER IMPLICATIONS: Trophoblast invasion in the first trimester of pregnancy remains poorly understood despite the importance of this process in the pathogenesis of pre-eclampsia, FGR, stillbirth and recurrent miscarriage. The new technologies described here will allow investigation into this critical process.

来源:Hum Reprod Update,查看原文。版权归原作者所有。

引用

  1. Abbas Y, Turco MY, Burton GJ, et al. Investigation of human trophoblast invasion in vitro. Hum Reprod Update. 2020. PMID: 32441309. doi:10.1093/humupd/dmaa017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。